Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who woulda thought huh?
Wow isn't that misleading! We're developing a covid vaccine???
Immediately following the acceptance of the RS the uplisting takes place. The RS split after-all is a necessary prerequisite for uplisting there's not some kind of conspiracy taking place and nobody has misled you.
Terry Donnelly Interview
And neither do you or I for that matter. It's all just speculation.
It's pretty clear to me that George Soros is controlling the price of Lexaria through 5G signals and also Bill Gates is investigating whether DehydraTECH can be used to get his vaccine tracking chip into the bloodstream without injection.
No, they're a co-packer for Hill Street.
CIBC is an eager buyer in Canada, they've bought net 105,500 so far.
A high-throughput screening campaign of a library of approved drugs and clinical candidates revealed six small molecules, ebselen, disulfiram, carmofur, tideglusib, shikonin and PX-12, as inhibitors of SARS-CoV-2 Mpro
"remdesivir...as well as three additional drugs known to target the main protease associated with SARS-CoV-2 infection."
The SARS-CoV-2 main protease as drug target.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331567/
We've only acquired the drug. IMO
To enhance bio-availability with an oral vaccine.
Thanks, Abundance, of course, you're right. DehydraTECH doesn't need licensing it's the facilities that need licensing and each product needs approval. Everyone producing a cannabis drink is claiming quick onset.
I'm still choked that we're over a year late to the party but things are starting to develop.
Molecule stays away from DehydraTECH even though there is an agreement between them and BEER. They've seen both techs and they've made their pick it would seem.
https://www.newswire.ca/news-releases/molecule-signs-supply-agreement-with-abcann-medicinals-inc-securing-use-of-vertosa-cannabis-emulsions-865021768.html
Sell!! LOL
Hello, resistance!
I'm sure the drug companies know what we're doing and are very interested in the results. There are almost unlimited numbers of drug candidates that could benefit from using DehydraTECH to dramatically increase bio-availability.
Darunavir or Prezista is made by ABBVIE Inc. Bioavailability: 37% (without ritonavir), 82% with ritonavir...
and
Efavirenz (EFV), sold under the brand names Sustiva is made by Mylan. Bioavailability: 40–45% (under fasting conditions)
They've gone from being a street dealer selling hits to a major distributor moving kilo and multi-kilo loads.
Thanks, the obvious question is why is Molecule paying for a different technology (nanoemulsion) when Hill Street is right there with DehydraTECH?
Do they see better results with this than with DehydraTECH, or is it cheaper?
Probably because Hill Street still doesn't have a license over a year after edibles were legalized in Canada, and there's no clear indication when or if they will ever receive one.
Molecule doesn't appear to have any interest in using Lexaria's tech.
https://candlr.com/2020/11/27/molecule-signs-supply-agreement-with-abcann-medicinals-inc-securing-use-of-vertosa-cannabis-emulsions/?fbclid=IwAR38L0E8PGzTp83lKUCJ3eHeiitW8tOZb1ZpJqQL9sO_0RZRjlE5dWGDsWU
BEER is bubbling up again with almost a half-million on the Bid.
There's nothing at all wrong with his posts, it's the monotonous repetition. 'Share price down, market up, management bad and overpaid, management should buy all the O/S shares on the market etc.'
Duh! You have to HOLD a fairly large position to be a market maker. You must be willing to buy and sell anytime so yes they always have a position whether it's short or long. They also may be trading in their own accounts and hold further shares there.
https://www.organigram.ca/innovation#nanotech
Nanoemulsion, so you know that they must be using cannabinoid isolates as opposed to the full spectrum oil that we use.
Organigram begins selling Edison Re:Mix powder
2020-11-17 07:00 ET - News Release
Mr. Greg Engel reports
ORGANIGRAM LAUNCHES EDISON RE:MIX RAPID DISSOLVABLE CANNABIS POWDER
Organigram Holdings Inc. has launched Edison Re:Mix dissolvable cannabis powder. Re:Mix is the latest innovation from the Company's Edison brand portfolio of products, offering Canadian adults the opportunity to enjoy cannabis their way.
Rapid dissolving and discreet formulations offer consumers highly customizable cannabis beverage experience;
Nanoemulsion formula offers improved absorption compared with traditional edibles;
Estimates suggest Canadian recreational cannabis beverage market represents $467-million category opportunity (i).
The convenient prepackaged powder format makes it easy to mix Edison Re:Mix into beverages quickly and discreetly, so the product can be enjoyed, based on the consumer's own preference, in a wide variety of settings and on occasions of their choosing.
"Edison Re:Mix showcases the creativity, focus and expertise of Organigram's product development team and reinforces our company commitment to growth through innovation," says Greg Engel, chief executive officer, Organigram. "We have developed a process and product that blend science and individual tastes to help adult Canadians explore new, personal cannabis experiences."
Key features of Edison Re:Mix include the following:
Customizable: Re:Mix can easily be added to almost any beverage, transforming it into a cannabis-infused drink in a matter of seconds (ii).
Rapid: Re:Mix dissolves rapidly into beverages for a quick, straightforward cannabis experience. In addition, the nanoemulsion formula provides improved absorption compared with traditional edibles, like a brownie or an ingestible oil.
Discreet: Re:Mix is odourless and mixes in clear to most drinks, making it a discreet addition. It also contains no added flavour.
The results of a recent Organigram survey suggest a significant majority of current cannabis consumers (74 per cent) would prefer to add cannabis to their beverages by themselves (versus a premixed beverage). The discreet nature of the product also addresses consumer concerns related to open cannabis consumption.
As previously announced, Organigram's researchers have developed a proprietary nano-emulsification technology that generates nano-droplets which are very small and uniform; this provides improved absorption compared with traditional solid edibles, potentially allowing for a more reliable and controlled experience.
With traditional edibles, beverages and ingestible oil-based extracts, the body spends significant time breaking down fat-soluble cannabinoid particles which are then absorbed and metabolized in the body before the effects are felt. This lengthy process can result in accidental overconsumption and undesirable experiences.
The nanoemulsion technology is also anticipated to have increased stability to temperature variations, mechanical disturbance, salinity, pH and sweeteners. The powdered formulation holds the potential to offer consumers a measured dose of cannabinoids which they can then add to liquid, such as a beverage of their choice, while also offering the discretion, portability and shelf life expected of a dried powder formulation.
Market opportunity
According to recent sales data in Colorado, cannabinoid-infused powders have rapidly risen to the top of the beverage category in popularity, representing 55 per cent of the state's beverage market sales. In fact, 46 per cent of cannabis consumers reported enjoying cannabinoid-infused beverages multiple times a day (iii).
In Canada, the recreational cannabis beverage market is expected to increase by 15 times its current market size over the next five years (iv).
Edison Re:Mix availability
Edison Re:Mix is available in three formats:
Two sachets with five milligrams of tetrahydrocannabinol per sachet;
Two sachets with 5:5 mg THC:CBD (cannabidiol) per sachet;
Five sachets with 10 mg CBD per sachet.
Edison Re:Mix will be available in certain provincial retail stores this month.
CIBC seems to be the big buyer in the Great White North this morning. They've bought the vast majority of shares so far, 141,000.
Merck Positioning to Take the Lead U.S. COVID-19 Antiviral Market from Remdesivir: EIDD-2801
https://www.trialsitenews.com/merck-positioning-to-take-the-lead-u-s-covid-19-antiviral-market-from-remdesivir-eidd-2801/
Shhhhhhh!
CBD/THC powder is going to be a huge part of the cannabis market going forward and we have the gold standard.
Permits should be in place in Canada soon to begin production and then we will see an almost instantaneous doubling of sales.
With Biden and Harris in power in the US and with legalization already in Canada the Cannabis powder market is set to become a multi-billion dollar opportunity and nobody has the quality product that Lexaria has. Full Spectrum.
Oh! I see you don't want a response after all. I thought you'd been complaining that you couldn't get a response.
Are you going to tell him every day what he should do? And you wonder why you don't get a response.